Strategy Inc. Lifescience Consulting
Strategy Inc. offers a full suite of strategic lifescience consulting services for essential financial and market due diligence combining rigorous analysis with decades of industry knowledge. Determining the value of innovation drives prioritization of resources, captures investment at the highest value and ensures selection of the indication with the highest probability for successful commercialization. Our clients include enterprise companies, financiers, and emerging companies with technologies in all stages of the product lifecycle; however, nearly half of the innovations where clients seek Strategy Inc. insight are preclinical.
Ask about our customizable deliverables to specifically meet your needs. Contact Us
- Market due diligence to validate target market and adoption forecasting
- Ensure commitment from anticipated end users to accelerate time to positive cash flow with a confirmed market strategy
- Market size and confirmed penetration rates for preclinical technology is the cornerstone to increased valuation
- Third party valuation by experienced Medtech financial advisors
- Externally validated analysis resonates with sophisticated investors who rarely give credence to internally generated valuation
- Scope of direct and indirect competitors, both current and future
- Grasp the complete landscape for your value proposition to prioritize the open space most receptive to accelerated adoption
- Pipeline technology evaluation considering market size, commercialization timeline and risk and other external factors to summarize
- Prioritize between divergent technologies, (med device, biologics, or pharmaceuticals) to focus resources first on products with the greatest potential
Global Focus: 46% of Strategy Inc. business over the last 10 years has been international, providing medical device consulting services to foreign entities seeking to bring their technology to market in the US.
Located in Austin, Texas, New York, New York, and Research Triangle Park, North Carolina, Strategy Inc., has global reach and works with entities in the US, Europe, Israel, Asia and South America.
Strategy Inc. provides medical device consulting services to venture capitalists, emerging technology companies, law firms specializing in emerging biomedical technology, multinational medical device companies and incubator/accelerators. Excerpts from selected client testimonials are shown below or view the Full Testimonials.
“Strategy Inc. has worked with a number of my companies on a variety of important strategic projects. I have found […]
“Strategy Inc. helped us to get a handle on an emerging therapeutic solution that provides a complete paradigm shift – […]
“Strategy Inc. worked with us on the Valuation and due diligence for an emerging stage innovative medical device technology. The […]
“Prior to allocating additional resources for expansion of our product portfolio, Strategy Inc. performed a worldwide market due diligence analysis […]
“As Senior Manager, Marketing & Commercialization at OrthoXel I commissioned Nancy Patterson and Strategy Inc. to run a deep intensive […]
“Strategy Inc. has supported us in every step of setting the foundation for the successful launch of our products in […]
“We hired Strategy Inc. to support our US Market Launch and identify KOLs with a lengthy list of criteria in […]
“We hired Strategy Inc. to identify US Key Opinion leaders in Ophthalmology, to support our fund raising efforts and calibrate […]
“Strategy Inc. was able to perform a market analysis and technology assessment that permitted our company to monetize our intellectual […]
“We used Strategy Inc. to perform a Business Analysis and Optimal Market Action Plan for a paradigm changing supply chain […]
“In working with Strategy Inc. on marketing claims analysis and market research, we found that their processes and hard work […]
“The highly professional, structured and focused process of competitive analysis conducted by Strategy Inc. contributed significantly and brought certainty to […]
“Strategy Inc. performed a business analysis for several of our biologic emerging technologies delivering a US market strategy. The due […]
“Strategy Inc. performed a TechSelect Analysis on eight of our developing technologies at LA BioMed, the Los Angeles Biomedical Research […]
“Strategy Inc. identified, validated and provided introductions to Key Opinion Leaders for the formation of our Scientific Advisory Board to […]
“Strategy Inc. researched and then introduced us to a broad spectrum of Key Opinion Leaders for the formation of our […]
“Strategy Inc. conducted several valuable medical device assessments that were critical in our evaluation of new project proposals. They provided […]
“Strategy Inc. assisted our company with the development of an Investor Presentation and a Valuation Top Line clarifying the value […]
“Strategy Inc. was recommended by our attorneys Stradling, Yocca, Carlson & Rauth, and we hired them to perform a valuation […]